Concurrent Investment Advisors, LLC Natera, Inc. Transaction History
Concurrent Investment Advisors, LLC
- $5.83 Trillion
- Q3 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 200 shares of NTRA stock, worth $37,720. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$37,720% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTRA
# of Institutions
721Shares Held
124MCall Options Held
590KPut Options Held
246K-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.39 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$2.3 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.39 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.28 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.82MShares$909 Million3.66% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $18.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...